Ana Quintero

Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors

Mario Durán‐Prado, Manuel D. Gahete, Antonio J. Martínez‐Fuentes et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 137 citations

Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder

Ana Quintero, Jose Alvarez‐Kindelán, Rafael J. Luque et al. · Journal of Clinical Pathology · 2006 · 98 citations · Full text

Prognostic Factors in Survival of Patients With Stage Ta and T1 Bladder Urothelial Tumors The Role of G 1 -S Modulators (p53, P21Waf1, p27Kip1, Cyclin D1, and Cyclin D3), Proliferation Index and Clinicopathologic Parameters

Antonio López-Beltrán, Rafael J. Luque, Jose Alvarez‐Kindelán et al. · American Journal of Clinical Pathology · 2004 · 85 citations · Full text

Detection of Insulitis by Pancreatic Scintigraphy With 99mTc-Labeled IL-2 and MRI in Patients With LADA (Action LADA 10)

Alberto Signore, Gabriela Capriotti, M. Chianelli et al. · Diabetes Care · 2015 · 43 citations

Loss of heterozygosity at 9q32–33 (DBC1 locus) in primary non‐invasive papillary urothelial neoplasm of low malignant potential and low‐grade urothelial carcinoma of the bladder and their associated normal urothelium

Antonio López-Beltrán, Jose Alvarez‐Kindelán, Ana Blanca et al. · The Journal of Pathology · 2008 · 36 citations

Low‐grade Urothelial Carcinoma, Low Malignant Potential, Pathology +17